Staar Surgical reported $63.87M in Gross Profit on Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abbott ABT:US USD 5.78B 543M
Atrion ATRI:US USD 20.83M 3.46M
Boston Scientific BSX:US USD 2.18B 42M
Cooper Companies COO:US USD 552.1M 19.6M
Exact Sciences EXAS:US USD 375.14M 1.9M
Hologic HOLX:US USD 522.9M 36.1M
Johnson & Johnson JNJ:US USD 15.98B 134M
Meridian Bioscience VIVO:US USD 33.99M 2.74M
Merit Medical Systems MMSI:US USD 128.57M 6.49M
Novartis NOVN:VX USD 9.18B 151M
Orasure Technologies OSUR:US USD 46.19M 18.61M
Valeant Pharmaceuticals VRX:CN USD 1.46B 72M